Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-22-000560
Date:2021-01-18
Issuer: INARI MEDICAL, INC. (NARI)
Original Submission Date:

Reporting Person:

HILL, MITCH C.
C/O INARI MEDICAL, INC.
6001 OAK CANYON, SUITE 100 IRVINE, CA 92618

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-01-18 M 7,500 a $0.46 74,941 direct
COMMON STOCK 2022-01-18 S 1,766 d $75.43 73,175 direct
COMMON STOCK 2022-01-18 S 2,783 d $76.54 70,392 direct
COMMON STOCK 2022-01-18 S 2,351 d $77.35 68,041 direct
COMMON STOCK 2022-01-18 S 600 d $78.26 67,788 direct
COMMON STOCK 2021-01-18 0 $0.00 1,600 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTIONS (RIGHT TO BUY) 0.457 2022-01-18 deemed execution date M 7,500 (d) 2029-04-23 common stock 7,500 $0.46 244,477 direct
Footnotes
IDfootnote
f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on august 23, 2021
f2 this transaction was executed in multiple trades at prices ranging from $74.95 to $75.82. the price reported above reflects the weighted average price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f3 this transaction was executed in multiple trades at prices ranging from $75.96 to $76.91. the price reported above reflects the weighted average price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f4 this transaction was executed in multiple trades at prices ranging from $76.99 to $77.94. the price reported above reflects the weighted average price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f5 this transaction was executed in multiple trades at prices ranging from $78.03 to $78.52. the price reported above reflects the weighted average price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f6 includes 347 shares acquired under the employee stock purchase plan.
f7 options vested with respected with 25% of the underlying shares on april 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment there after.
WhaleWisdom Logo

Elevate your investments